What is it about?
Gastroesophageal reflux disease (GERD) was a term devised to conceptualize the array of symptoms and potential complications that can occur from the excessive reflux of gastric content into the esophagus. In general, GERD develops through a combination of age-related change and the increased abdominal pressure associated with abdominal obesity. However, translating the concept of GERD into practice had led to much confusion and several contradictions in how the "disease" is diagnosed and managed. This article analyzes these contradictions and how they have led to large scale over-diagnosis and over-treatment of GERD.
Featured Image
Why is it important?
The major drug class used to treat GERD are the proton pump inhibitors (PPIs). Because of large scale over-diagnosis and over-treatment of GERD, these have become among the most commonly prescribed and used drugs in the world. This has resulted in massive population exposure on the assumption that the drugs are perfectly safe. However, no drug is perfectly safe and the past 5 years have seen a steady stream of reports associating chronic PPI use with a wide array of potentially serious conditions including bone fracture, chronic kidney disease, dementia, nutrient deficiencies and infections.
Perspectives
We wrote this article to make physicians and patients appreciate the array of management options available for treating heartburn (the major symptom of GERD), including simple life-style modifications, and to help them critically analyze the massive emerging literature on PPI safety
Peter Kahrilas
Northwestern University
Read the Original
This page is a summary of: Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease, F1000Research, September 2017, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.11918.1.
You can read the full text:
Contributors
The following have contributed to this page







